Tapinator, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows, 13 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-11-22: Reporting owner GLASS DESMOND; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-11-05: Reporting owner FELDMAN SPENCER G; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-09-30: Reporting owner Nikolayev Ilya; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2019-09-30: Reporting owner Chan Brian; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-11-22 | GLASS DESMOND Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.06 exercise price | 2019-11-26 | |
| 2019-11-05 | FELDMAN SPENCER G Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.05 exercise price | 2019-11-13 | |
| 2019-09-30 | Nikolayev Ilya Director, Officer (Chief Executive Officer), 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000,000 5,000,000 owned after | $0.06 exercise price | 2019-10-02 | |
| 2019-09-30 | Chan Brian Officer (VP Finance and Accounting Sec.) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $0.06 exercise price | 2019-10-02 | |
| 2019-09-30 | MERKATZ ANDREW Director, Officer (President and CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000,000 5,000,000 owned after | $0.06 exercise price | 2019-10-02 | |
| 2019-09-30 | Farman-Farmaian Teymour M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $0.06 exercise price | 2019-10-02 | |
| 2018-04-30 holding as of filing | Nikolayev Ilya Director, Officer (Chief Executive Officer), 10% Owner | 3 | Options to Purchase Common Stock Derivative · Direct | Holding | $0.11 exercise price | 2018-04-30 | ||
| 2018-04-30 holding as of filing | MERKATZ ANDREW Director, Officer (President and CFO) | 3 | Options to Purchase Common Stock Derivative · Direct | Holding | $0.11 exercise price | 2018-04-30 | ||
| 2018-04-30 holding as of filing | Farman-Farmaian Teymour M Director | 3 | Options to Purchase Common Stock Derivative · Direct | Holding | $0.33 exercise price | 2018-04-30 | ||
| 2018-04-30 holding as of filing | Farman-Farmaian Teymour M Director | 3 | Options to Purchase Common Stock Derivative · Direct | Holding | $0.11 exercise price | 2018-04-30 | ||
| 2018-04-30 holding as of filing | Crates Robert Bruce Director | 3 | Options to Purchase Common Stock Derivative · Direct | Holding | $0.11 exercise price | 2018-04-30 | ||
| 2018-04-30 holding as of filing | Chan Brian Officer (VP Finance and Accounting Sec.) | 3 | Options to Purchase Common Stock Derivative · Direct | Holding | $0.19 exercise price | 2018-04-30 | ||
| 2018-04-30 holding as of filing | Chan Brian Officer (VP Finance and Accounting Sec.) | 3 | Options to Purchase Common Stock Derivative · Direct | Holding | $0.11 exercise price | 2018-04-30 |